Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 5180707, 8 pages
https://doi.org/10.1155/2017/5180707
Research Article

Helicteric Acid, Oleanic Acid, and Betulinic Acid, Three Triterpenes from Helicteres angustifolia L., Inhibit Proliferation and Induce Apoptosis in HT-29 Colorectal Cancer Cells via Suppressing NF-κB and STAT3 Signaling

1College of Materials Science and Food Engineering, Zhongshan Institute, University of Electronic Science and Technology of China, Zhongshan, Guangdong 528400, China
2The Zhongshan Affiliated Hospital, Guangzhou University of Chinese Medicine, Zhongshan, Guangdong 528401, China

Correspondence should be addressed to Yu-qiao Gao; moc.361@yksoaiqa

Received 21 November 2016; Accepted 8 February 2017; Published 26 February 2017

Academic Editor: Luigi Ricciardiello

Copyright © 2017 Dan Su et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, C. Desantis, and A. Jemal, “Colorectal cancer statistics, 2014,” CA Cancer Journal for Clinicians, vol. 64, no. 2, pp. 104–117, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Watanabe, M. Itabashi, Y. Shimada et al., “Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer,” International Journal of Clinical Oncology, vol. 17, no. 1, pp. 1–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. A. T. Chan and E. L. Giovannucci, “Primary prevention of colorectal cancer,” Gastroenterology, vol. 138, no. 6, pp. 2029–2043.e10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Liu, R. Zheng, M. Zhang, S. Zhang, X. Sun, and W. Chen, “Incidence and mortality of colorectal cancer in China, 2011,” Chinese Journal of Cancer Research, vol. 27, no. 1, pp. 22–28, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. E. van Cutsem, B. Nordlinger, and A. Cervantes, “Advanced colorectal cancer: ESMO clinical practice guidelines for treatment,” Annals of Oncology, vol. 21, supplement 5, pp. v93–v97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. K. Dyson and M. D. Rutter, “Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?” World Journal of Gastroenterology, vol. 18, no. 29, pp. 3839–3848, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Terzić, S. Grivennikov, E. Karin, and M. Karin, “Inflammation and colon cancer,” Gastroenterology, vol. 138, no. 6, pp. 2101.e5–2114.e5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S. I. Grivennikov, F. R. Greten, and M. Karin, “Immunity, inflammation, and cancer,” Cell, vol. 140, no. 6, pp. 883–899, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Klampfer, “Cytokines, inflammation and colon cancer,” Current Cancer Drug Targets, vol. 11, no. 4, pp. 451–464, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Knüpfer and R. Preiss, “Serum interleukin-6 levels in colorectal cancer patients—a summary of published results,” International Journal of Colorectal Disease, vol. 25, no. 2, pp. 135–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. K. S. Siveen, S. Sikka, R. Surana et al., “Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors,” Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, vol. 1845, no. 2, pp. 136–154, 2014. View at Google Scholar
  12. E. Elinav, R. Nowarski, C. A. Thaiss, B. Hu, C. Jin, and R. A. Flavell, “Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms,” Nature Reviews Cancer, vol. 13, no. 11, pp. 759–771, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. H. J. Kim, N. Hawke, and A. S. Baldwin, “NF-κB and IKK as therapeutic targets in cancer,” Cell Death and Differentiation, vol. 13, no. 5, pp. 738–747, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Bollrath and F. R. Greten, “IKK/NF-κB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis,” EMBO Reports, vol. 10, no. 12, pp. 1314–1319, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Khazir, B. A. Mir, L. Pilcher, and D. L. Riley, “Role of plants in anticancer drug discovery,” Phytochemistry Letters, vol. 7, no. 1, pp. 173–181, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. M.-H. Teiten, F. Gaascht, M. Dicato, and M. Diederich, “Anticancer bioactivity of compounds from medicinal plants used in European medieval traditions,” Biochemical Pharmacology, vol. 86, no. 9, pp. 1239–1247, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. G. M. Cragg and D. J. Newman, “Plants as a source of anti-cancer agents,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 72–79, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. M.-H. Pan, C.-M. Chen, S.-W. Lee, and Z.-T. Chen, “Cytotoxic triterpenoids from the root bark of Helicteres angustifolia,” Chemistry and Biodiversity, vol. 5, no. 4, pp. 565–574, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. Q. Huang, R. Huang, L. Wei et al., “Antiviral activity of methyl helicterate isolated from Helicteres angustifolia (Sterculiaceae) against hepatitis B virus,” Antiviral Research, vol. 100, no. 2, pp. 373–381, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Chen, W. Tang, L. Lou, and W. Zhao, “Pregnane, coumarin and lupane derivatives and cytotoxic constituents from Helicteres angustifolia,” Phytochemistry, vol. 67, no. 10, pp. 1041–1047, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Lin, R. Huang, S. Zhang et al., “Methyl helicterate protects against CCl4-induced liver injury in rats by inhibiting oxidative stress, NF-κB activation, Fas/FasL pathway and cytochrome P4502E1 level,” Food and Chemical Toxicology, vol. 50, no. 10, pp. 3413–3420, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. Y.-S. Chang, Y.-R. Ku, J.-H. Lin, K.-L. Lu, and L.-K. Ho, “Analysis of three lupane type triterpenoids in Helicteres angustifolia by high-performance liquid chromatography,” Journal of Pharmaceutical and Biomedical Analysis, vol. 26, no. 5-6, pp. 849–855, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-Q. Gao, D. Su, Y. Hu, H. Lin, W.-X. Zhang, and W.-B. Dai, “Effect of Helicteres angustifolia on rats with ulcerative colitis,” Journal of Chinese Medicinal Materials, vol. 36, no. 4, pp. 597–600, 2013. View at Google Scholar · View at Scopus
  24. Y. Q. Gao, D. Su, Y. G. Liang, T. Y. Zhang, and Q. X. Mei, “Study on triterpenoids from Helicteres angustifolia by high-speed countercurrent chromatography,” Zhong Yao Cai, vol. 39, no. 5, pp. 1053–1056, 2016 (Chinese). View at Google Scholar
  25. R. Kalluri and R. A. Weinberg, “The basics of epithelial-mesenchymal transition,” Journal of Clinical Investigation, vol. 119, no. 6, pp. 1420–1428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. I. Grivennikov and M. Karin, “Inflammation and oncogenesis: a vicious connection,” Current Opinion in Genetics & Development, vol. 20, no. 1, pp. 65–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Medzhitov, “Origin and physiological roles of inflammation,” Nature, vol. 454, no. 7203, pp. 428–435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, “Cancer-related inflammation,” Nature, vol. 454, no. 7203, pp. 436–444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. W.-W. Lin and M. Karin, “A cytokine-mediated link between innate immunity, inflammation, and cancer,” The Journal of Clinical Investigation, vol. 117, no. 5, pp. 1175–1183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Ancrile, K.-H. Lim, and C. M. Counter, “Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis,” Genes and Development, vol. 21, no. 14, pp. 1714–1719, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Yu, D. Pardoll, and R. Jove, “STATs in cancer inflammation and immunity: a leading role for STAT3,” Nature Reviews Cancer, vol. 9, no. 11, pp. 798–809, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Ben-Neriah and M. Karin, “Inflammation meets cancer, with NF-κB as the matchmaker,” Nature Immunology, vol. 12, no. 8, pp. 715–723, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Karin and F. R. Greten, “NF-κB: linking inflammation and immunity to cancer development and progression,” Nature Reviews Immunology, vol. 5, no. 10, pp. 749–759, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Pikarsky, R. M. Porat, I. Stein et al., “NF-κB functions as a tumour promoter in inflammation-associated cancer,” Nature, vol. 431, no. 7007, pp. 461–466, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. F. R. Greten, L. Eckmann, T. F. Greten et al., “IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer,” Cell, vol. 118, no. 3, pp. 285–296, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Fletcher, J. A. Drewry, V. M. Shahani, B. D. G. Page, and P. T. Gunning, “Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein,” Biochemistry and Cell Biology, vol. 87, no. 6, pp. 825–833, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. S. H. Yang, D. B. Khadka, S. H. Cho et al., “Virtual screening and synthesis of quinazolines as novel JAK2 inhibitors,” Bioorganic and Medicinal Chemistry, vol. 19, no. 2, pp. 968–977, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. N. D. Perkins, “The diverse and complex roles of NF-κB subunits in cancer,” Nature Reviews Cancer, vol. 12, no. 2, pp. 121–132, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Sasaki, T. Morisaki, K. Hashizume et al., “Nuclear factor-κB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue,” Clinical Cancer Research, vol. 7, no. 12, pp. 4136–4142, 2001. View at Google Scholar · View at Scopus
  41. S. Grivennikov, E. Karin, J. Terzic et al., “IL-6 and Stat3 Are required for survival of intestinal epithelial cells and development of colitis-associated cancer,” Cancer Cell, vol. 15, no. 2, pp. 103–113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Bollrath, T. J. Phesse, V. A. von Burstin et al., “gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis,” Cancer Cell, vol. 15, no. 2, pp. 91–102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. F. M. Corvinus, C. Orth, R. Moriggl et al., “Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth,” Neoplasia, vol. 7, no. 6, pp. 545–555, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Shalapour and M. Karin, “Immunity, inflammation, and cancer: an eternal fight between good and evil,” The Journal of Clinical Investigation, vol. 125, no. 9, pp. 3347–3355, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Wieczorek, T. Ginter, P. Brand, T. Heinzel, and O. H. Krämer, “Acetylation modulates the STAT signaling code,” Cytokine and Growth Factor Reviews, vol. 23, no. 6, pp. 293–305, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Bromberg and T. C. Wang, “Inflammation and cancer: IL-6 and STAT3 complete the link,” Cancer Cell, vol. 15, no. 2, pp. 79–80, 2009. View at Publisher · View at Google Scholar · View at Scopus